Related references
Note: Only part of the references are listed.Life and death by death receptors
Maria Eugenia Guicciardi et al.
FASEB JOURNAL (2009)
Human Caspases: Activation, Specificity, and Regulation
Cristina Pop et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2009)
Modulation of death receptors by cancer therapeutic agents
Heath A. Elrod et al.
CANCER BIOLOGY & THERAPY (2008)
Norcantharidin-induced apoptosis in oral cancer cells is associated with an increase of proapoptotic to antiapoptotic protein ratio
SH Kok et al.
CANCER LETTERS (2005)
Cisplatin-induced apoptosis in Hep3B cells: mitochondria-dependent and -independent pathways
JS Kim et al.
BIOCHEMICAL PHARMACOLOGY (2004)
Effector mechanisms of norcantharidin-induced mitotic arrest and apoptosis in human hepatoma cells
YN Chen et al.
INTERNATIONAL JOURNAL OF CANCER (2002)
Induction of apoptosis by norcantharidin in human colorectal carcinoma cell lines: involvement of the CD95 receptor/ligand
F Peng et al.
JOURNAL OF CANCER RESEARCH AND CLINICAL ONCOLOGY (2002)
Overexpression of the mouse Fas gene in human Hep3B hepatoma cells overcomes their resistance to Fas-mediated apoptosis
C Lamboley et al.
JOURNAL OF HEPATOLOGY (2002)
Actinomycin D and gemcitabine synergistically sensitize androgen-independent prostate cancer cells to Apo2L/TRAIL-mediated apoptosis
A Zisman et al.
JOURNAL OF IMMUNOTHERAPY (2001)
Anticancer activity evaluation of the Solanum glycoalkaloid solamargine -: Triggering apoptosis in human hepatoma cells
KW Kuo et al.
BIOCHEMICAL PHARMACOLOGY (2000)
Norcantharidin-induced post-G2/M apoptosis is dependent on wild-type p53 gene
CY Hong et al.
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS (2000)
Failure of Bcl-2 to block cytochrome c redistribution during TRAIL-induced apoptosis
SA Keogh et al.
FEBS LETTERS (2000)
Chemotherapeutic agents augment TRAIL-induced apoptosis in human hepatocellular carcinoma cell lines
T Yamanaka et al.
HEPATOLOGY (2000)
Share Paper
